W. Dieterle

1.1k total citations
50 papers, 877 citations indexed

About

W. Dieterle is a scholar working on Molecular Biology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, W. Dieterle has authored 50 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Pharmacology and 11 papers in Analytical Chemistry. Recurrent topics in W. Dieterle's work include Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Analytical Chemistry and Chromatography (7 papers). W. Dieterle is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Analytical Methods in Pharmaceuticals (9 papers) and Analytical Chemistry and Chromatography (7 papers). W. Dieterle collaborates with scholars based in Switzerland, France and Germany. W. Dieterle's co-authors include J. W. Faigle, Gérard Flesch, W Theobald, Peter Lloyd, Jessica Mann, James Mann, G. Kaiser, Sujata Vaidyanathan, Roland Ackermann and P.H. Degen and has published in prestigious journals such as Cancer Research, Journal of Chromatography A and Epilepsia.

In The Last Decade

W. Dieterle

48 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Dieterle Switzerland 18 182 181 171 170 165 50 877
C. H. Kleinbloesem Switzerland 15 262 1.4× 291 1.6× 164 1.0× 146 0.9× 264 1.6× 28 1.1k
R N Boyes United Kingdom 19 251 1.4× 167 0.9× 200 1.2× 147 0.9× 104 0.6× 26 1.1k
Douglas S. Greene United States 20 268 1.5× 103 0.6× 487 2.8× 236 1.4× 154 0.9× 66 1.4k
J. Godbillon Switzerland 24 188 1.0× 95 0.5× 286 1.7× 107 0.6× 181 1.1× 61 1.3k
HF Woods United Kingdom 17 372 2.0× 91 0.5× 174 1.0× 335 2.0× 135 0.8× 28 1.2k
N. Rietbrock Germany 19 218 1.2× 196 1.1× 109 0.6× 361 2.1× 147 0.9× 147 1.4k
C. Harvengt Belgium 18 155 0.9× 149 0.8× 193 1.1× 240 1.4× 90 0.5× 100 1.0k
John J. Ashley Australia 16 141 0.8× 84 0.5× 106 0.6× 106 0.6× 216 1.3× 24 815
H. J. Dengler Germany 19 404 2.2× 134 0.7× 179 1.0× 238 1.4× 186 1.1× 44 1.2k
Linyee Shum United States 12 101 0.6× 186 1.0× 91 0.5× 271 1.6× 67 0.4× 23 782

Countries citing papers authored by W. Dieterle

Since Specialization
Citations

This map shows the geographic impact of W. Dieterle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Dieterle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Dieterle more than expected).

Fields of papers citing papers by W. Dieterle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Dieterle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Dieterle. The network helps show where W. Dieterle may publish in the future.

Co-authorship network of co-authors of W. Dieterle

This figure shows the co-authorship network connecting the top 25 collaborators of W. Dieterle. A scholar is included among the top collaborators of W. Dieterle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Dieterle. W. Dieterle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bauer, Martin, H Bliesath, Chiara Leuratti, et al.. (2010). Disposition and Metabolism of Ralfinamide, a Novel Na-Channel Blocker, in Healthy Male Volunteers. Pharmacology. 86(5-6). 297–305. 6 indexed citations
2.
Dieterle, W. & Thomas Hengelage. (2008). Influence of food intake on the pharmacokinetics of avosentan in man. International Journal of Clinical Pharmacology and Therapeutics. 46(9). 453–458. 1 indexed citations
3.
Dieterle, W. & James Mann. (2006). Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. 44(7). 326–330. 2 indexed citations
4.
Dieterle, W., Johannes F.E. Mann, & Klaus Kutz. (2005). Multiple-dose pharmacokinetics, pharmaco- dynamics and tolerability of the oral ETA endothelin-receptor antagonist SPP301 in man. International Journal of Clinical Pharmacology and Therapeutics. 43(4). 178–186. 4 indexed citations
5.
Dieterle, W., et al.. (2005). Pharmacokinetic interactions of the oral renin inhibitor aliskiren with lovastatin, atenolol, celecoxib and cimetidine. International Journal of Clinical Pharmacology and Therapeutics. 43(11). 527–535. 71 indexed citations
6.
Dieterle, W., et al.. (2004). Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 58(4). 433–436. 64 indexed citations
7.
Dieterle, W., Jessica Mann, & Klaus Kutz. (2003). Pharmacokinetics and Pharmacodynamics of the ETA‐Selective Endothelin Receptor Antagonist SPP301 in Healthy Human Subjects. The Journal of Clinical Pharmacology. 44(1). 59–66. 14 indexed citations
8.
Cardot, J, et al.. (1995). Comparison of plasma and saliva concentrations of the active monohydroxy metabolite of oxcarbazepine in patients at steady state. Biopharmaceutics & Drug Disposition. 16(7). 603–614. 21 indexed citations
9.
Degen, P.H., et al.. (1994). The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharmaceutics & Drug Disposition. 15(6). 519–526. 23 indexed citations
10.
Flesch, Gérard, et al.. (1994). Quantitative determination of CGP 53 437, a new HIV protease inhibitor, in plasma by high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 155–161. 2 indexed citations
11.
Lloyd, Peter, Gérard Flesch, & W. Dieterle. (1994). Clinical Pharmacology and Pharmacokinetics of Oxcarbazepine. Epilepsia. 35(s3). S10–3. 121 indexed citations
12.
Kaiser, G., et al.. (1993). Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria. European Journal of Clinical Pharmacology. 44(5). 463–466. 4 indexed citations
13.
Degen, P.H., et al.. (1993). Influence of food on the disposition of the monoamine oxidase‐A inhibitor brofaromine in healthy volunteers. Biopharmaceutics & Drug Disposition. 14(3). 209–215. 1 indexed citations
14.
Kaiser, G., Roland Ackermann, W. Dieterle, I. W. Reimann, & P. R. Bieck. (1992). Pharmacokinetics of the antidepressant levoprotiline after intravenous and peroral administration in healthy volunteers. Biopharmaceutics & Drug Disposition. 13(2). 83–93. 2 indexed citations
15.
Ackermann, Roland, et al.. (1991). Determination of the antidepressant levoprotiline and itsN-desmethyl metabolite in biological fluids by gas chromatography/mass spectrometry. Journal of Mass Spectrometry. 20(11). 709–716. 1 indexed citations
16.
Kaiser, G., Roland Ackermann, W. Dieterle, et al.. (1990). Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. European Journal of Clinical Pharmacology. 38(4). 379–385. 21 indexed citations
17.
Kaiser, G., et al.. (1989). Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril·HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration. Biopharmaceutics & Drug Disposition. 10(4). 365–376. 32 indexed citations
18.
Degen, P.H., et al.. (1988). Pharmacokinetics of Diclofenac and Five Metabolites After Single Doses in Healthy Volunteers and After Repeated Doses in Patients. Xenobiotica. 18(12). 1449–1455. 29 indexed citations
19.
Winkler, Tammo, et al.. (1984). The Structure of Diastereomeric Oxaprotiline Metabolites. An NMR Study. Helvetica Chimica Acta. 67(8). 2082–2086. 2 indexed citations
20.
Dieterle, W., et al.. (1976). Metabolism of phenylbutazone in man.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 26(4). 572–7. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. H. Kleinbloesem Breakdown of academic impact, for papers by R N Boyes Breakdown of academic impact, for papers by Douglas S. Greene Breakdown of academic impact, for papers by J. Godbillon Breakdown of academic impact, for papers by HF Woods Breakdown of academic impact, for papers by N. Rietbrock Breakdown of academic impact, for papers by C. Harvengt Breakdown of academic impact, for papers by John J. Ashley Breakdown of academic impact, for papers by H. J. Dengler Breakdown of academic impact, for papers by Linyee Shum
Rankless by CCL
2026